Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy

Natalizumab is an approved medication for highly active multiple sclerosis (MS). Progressive multifocal leukoencephalopathy (PML) may occur as a severe side effect of this drug. Here, we describe pathological and radiological characteristics of immune reconstitution inflammatory syndrome (IRIS), whi...

Full description

Saved in:
Bibliographic Details
Main Authors: Metz, Imke, Radue, Ernst-Wilhelm, Oterino, Agustin, Kümpfel, Tania, Wiendl, Heinz, Schippling, Sven, Kuhle, Jens, Sahraian, Mohammad Ali, Gray, Francoise, Jakl, Veronika, Häusler, Darius, Brück, Wolfgang
Format: Artigo
Language:Inglês
Published: Springer-Verlag 2011
Subjects:
Original Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3259335/
https://ncbi.nlm.nih.gov/pubmed/22057786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00401-011-0900-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items